Country for PR: United States
Contributor: PR Newswire New York
Tuesday, July 27 2021 - 20:00
AsiaNet
New Mountain Capital to Acquire Flexan
NEW YORK, July 27, 2021 /PRNewswire-AsiaNet/ --

An affiliate of New Mountain Capital, LLC ("New Mountain") announced that it 
has reached a definitive agreement to acquire Flexan, a leading medical device 
contract design and manufacturing organization that specializes in silicone, 
thermoplastic, and specialty rubber components and devices.  Flexan will be 
acquired by ILC Dover, a New Mountain Capital portfolio company. The 
transaction is expected to close by August 2021 subject to customary closing 
conditions and regulatory approvals.

Photo - https://mma.prnewswire.com/media/1581732/ILC_Flexan_PR.jpg

Headquartered in Lincolnshire, IL, Flexan is a full-service leading contract 
design and manufacturing organization specializing in high-precision silicone, 
rubber, and thermoplastic components for the medical device industry. Founded 
in 1946, Flexan serves many of the world's most respected medical device 
companies who value Flexan's exceptional track-record, commitment to quality, 
and superior execution. By partnering with ILC Dover, the combined company will 
have the ability to leverage their respective expertise and capabilities to 
serve a broader client base situated in both medical device and 
biopharmaceutical end markets.

"Flexan's expertise in silicone molding and thermoplastic extrusion enables the 
company to deliver mission-critical components and devices to medical device 
manufacturers and ultimately improve patient care," said Andre Moura, Managing 
Director at New Mountain Capital.  "We look forward to working closely with the 
management teams at Flexan and ILC Dover to drive the next chapter of growth 
and innovation across life sciences markets."

This is the second acquisition ILC Dover has completed since announcing a 
partnership with New Mountain Capital in early 2020. The acquisition will 
continue to grow ILC Dover's life sciences solutions for its global customer 
base, including for the pharmaceutical and biopharmaceutical end markets.

Simpson Thacher & Bartlett LLP acted as legal counsel to New Mountain Capital 
and Kirkland & Ellis LLP acted as legal counsel to Flexan. BNP Paribas served 
as financial advisor to New Mountain Capital and Baird served as the financial 
advisor to Flexan.

About New Mountain Capital:
New Mountain Capital is a New York-based investment firm that emphasizes 
business building and growth, rather than debt, as it pursues long-term capital 
appreciation. The firm currently manages private equity, public equity, and 
credit funds with over $33 billion in assets under management. New Mountain 
seeks out what it believes to be the highest quality growth leaders in 
carefully selected industry sectors and then works intensively with management 
to build the value of these companies. For more information on New Mountain 
Capital, please visit www.newmountaincapital.com

About ILC Dover:
ILC Dover is a world-leader in the innovative design and production of 
engineered flexible protective solutions for pharmaceutical and 
biopharmaceutical, flood protection, personal protection, bulk packaging, and 
aerospace industries. Our customers will attest to our relentless dedication to 
high value products, advanced technology, and responsive service, as our 
visionary solutions have improved efficiency while safeguarding people, 
product, and infrastructure in hazardous conditions through flexible protective 
solutions since 1947. For more information on ILC Dover, please visit 
www.ilcdover.com 

Disclaimer:
This press release contain statements that may constitute "forward looking 
statements" including and without limitation, statements relating to product 
characteristics and uses, sales potential   and target dates for product launch 
, implementation of strategic initiatives, and other statements relating to our 
future business developments and economic performance. While these forward 
looking statements represent our judgment and future expectations concerning 
the development of our business, a number of risks, uncertainties and other 
factors could cause actual developments and results to differ materially from 
our expectations. The company undertakes no obligation to publicly revise any 
forward looking statements to reflect future events or circumstances and will 
not be held liable for any use of this information.

Source - New Mountain Capital

CONTACT: For New Mountain Capital: Dana Gorman / Matthew Butler, Abernathy 
MacGregor, dtg@abmac.com / msb@abmac.com, 212-371-5999; For Flexan: Mike 
Huiras, mike.huiras@flexan.com, 224-543-0156
Translations

Japanese